| ZALGAMI Prothena Therapeutics Limited 1900061 12 Jan 2018 | Registered: Registered/protected | Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis | |
